Study: NCT03466567

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: A single dose of 3 mg semaglutide tablet alone will be administered orally. Trial product administration will take place in the morning after overnight fasting for at least 6 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: A single dose of 3 mg semaglutide tablet alone will be administered orally. Trial product administration will take place in the morning after overnight fasting for at least 6 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: A single dose of 3 mg semaglutide tablet alone will be administered orally. Trial product administration will take place in the morning after overnight fasting for at least 6 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Probenecid
Description: A dose of 500 mg probenecid (2 tablets of 250 mg) will be administered orally twice daily for 3½ days (7 trial product administrations in total). On the 4th day, the last probenecid administration will take place 2 hours prior to administration of a single dose of 3 mg oral semaglutide tablet. The last trial product administrations will take place in the morning after overnight fasting for at least 6 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Probenecid
Description: A dose of 500 mg probenecid (2 tablets of 250 mg) will be administered orally twice daily for 3½ days (7 trial product administrations in total). On the 4th day, the last probenecid administration will take place 2 hours prior to administration of a single dose of 3 mg oral semaglutide tablet. The last trial product administrations will take place in the morning after overnight fasting for at least 6 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Probenecid
Description: A dose of 500 mg probenecid (2 tablets of 250 mg) will be administered orally twice daily for 3½ days (7 trial product administrations in total). On the 4th day, the last probenecid administration will take place 2 hours prior to administration of a single dose of 3 mg oral semaglutide tablet. The last trial product administrations will take place in the morning after overnight fasting for at least 6 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciclosporin
Description: A single dose of 600 mg ciclosporin (6 capsules of 100 mg) will be administered orally 1 hour prior to administration of a single dose of 3 mg oral semaglutide tablet. Trial product administration will take place in the morning after overnight fasting for at least 6 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciclosporin
Description: A single dose of 600 mg ciclosporin (6 capsules of 100 mg) will be administered orally 1 hour prior to administration of a single dose of 3 mg oral semaglutide tablet. Trial product administration will take place in the morning after overnight fasting for at least 6 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciclosporin
Description: A single dose of 600 mg ciclosporin (6 capsules of 100 mg) will be administered orally 1 hour prior to administration of a single dose of 3 mg oral semaglutide tablet. Trial product administration will take place in the morning after overnight fasting for at least 6 hours.